Continuous Renal Replacement therapy (CRRT) is a process of extracorporeal blood purification which is intended to substitute for impaired renal function for extended period of time. Continuous Renal Replacement therapy intends at application over 24 hours a day. It is a mode of renal replacement therapy for hemodynamically unstable, fluid over loaded and catabolic septic patients. The major application of CRRT is management of acute renal failure especially in critical care and intensive care units. The acceptance of CRRT with the renal failure patients at the critical stage is increasing due to the high survival rate.
Continuous Renal Replacement Therapy Market: Drivers & Restraints
The global continuous renal replacement therapy market is driven by the factors such as rising prevalence of Acute Kidney Injury (AKI), awareness about the blood purification technique increasing the adoption rate of continuous renal replacement therapy. In addition, the increased prevalence of sepsis, rapid rise in aging population are the major factor driving the CRRT market. Clinical advantages over CRRT is resulting in the growth of CRRT market. However the need of trained ICU nurses, complexity of the therapy, elevated cost of therapy are the major restraining factors of continuous renal replacement therapy market.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1211
Continuous Renal Replacement Therapy Market: Segmentation
Continuous renal replacement therapy market is classified on the basis of product, modalities and geography.
Based on product, the global continuous renal replacement therapy market is segmented into the following:
- CRRT systems
- CRRT disposables
- Replacement fluids
Based on modalities, the global continuous renal replacement therapy market is segmented into the following:
- Slow continuous ultrafiltration (SCUF)
- Continuous venovenous hemodialysis (CVVHD)
- Continuous venovenous hemofiltration (CVVH)
- Continuous venovenous hemodiafilteration (CVVHDF)
Continuous Renal Replacement Therapy Market: Overview
Continuous renal replacement therapy market is estimated to be growing faster due to the ongoing researches to satisfy safety and efficacy profiles of CRRT. The broadening applications of CRRT and development of CRRT system for pediatric patients are creating opportunities for the continuous renal replacement therapy market. The continuous renal replacement therapy is broadly used for hemodynamically unstable AKI patients. However, it is widely adopted due to high survival rate of patients. The CRRT market provides flexibility to the users owing to the range of alternatives in modalities. The continuous venovenous hemofiltration (CVVH) is expected to grow faster due to the high filtrate flow which will enhance the performance in terms of removing the solute. The continuous venovenous hemodialysis is estimated to grow owing to its ability of clearance of medium sized solutes.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1211
Continuous Renal Replacement Therapy Market: Region-wise Outlook
Depending on geographic regions, the global Continuous Renal Replacement therapy market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. Europe is estimated to be the largest market due to increased prevalence of AKI in the region followed by rise in aging population. Additionally, approval of CRRT machine and anti-coagulants for multiple application in Europe indicates the growth of CRRT market in the region. The emerging markets such as India and China are creating demand for CRRT due to the factors such as developing healthcare infrastructure, increasing aging population and rising indications of acute kidney injury (AKI).
Continuous Renal Replacement Therapy Market: Key Players
Some of the key players identified in the continuous renal replacement therapy market are B. Braun Medical Inc., Baxter, Medical Components, Inc., Nikkiso Co., Ltd, Fresenius Medical Care, INFOMED SA, Medica S.p.A., Toray medical Co., Ltd , asahi kasei medical Co.,Ltd , NxStage Medical, Inc. The companies are focusing on launches, acquisition, and geographic expansion.